Andreas Halvorsen: portfolio of Viking Global Investors
Andreas Halvorsen leads Viking Global Investors, a hedge fund that analyzes stocks worldwide and combines long and short positions.
Source: 13F filing with the US Securities and Exchange Commission dated Nov 14, 2024. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
You are looking at Q3 2024. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 27.4B USD
- Positions
- 83
- Share of the ten largest
- 38.6%
The ten largest positions Q3 2024
- U.S. Bancorp 5.6%▲ +32.3%
- Adobe Inc. 4.9%▲ +15.1%
- Apple Inc. 4.1%▲ +5.8%
- Philip Morris International 4.0%▼ −17.0%
- Visa Inc. 3.5%new
- Spotify Technology S A 3.5%▲ +442.7%
- Fortive 3.4%▲ +17.5%
- Progressive Corporation 3.2%▼ −13.0%
- Microsoft 3.2%▼ −10.8%
- Api Group Corp 3.1%▼ −4.9%
Show all positions of this quarter
Choose a quarter (54 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
- Q3 2016
- Q2 2016
- Q1 2016
- Q4 2015
- Q3 2015
- Q2 2015
- Q1 2015
- Q4 2014
- Q3 2014
- Q2 2014
- Q1 2014
- Q4 2013
- Q3 2013
- Q2 2013
All positions Q3 2024
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| USB U.S. Bancorp | 5.6% | 33,617,210 | 1.5B USD | +32.3% increased | Q4 2023 4 quarters |
| ADBE Adobe Inc. | 4.9% | 2,621,398 | 1.4B USD | +15.1% increased | Q1 2024 3 quarters |
| AAPL Apple Inc. | 4.1% | 4,859,142 | 1.1B USD | +5.8% increased | Q1 2024 3 quarters |
| PM Philip Morris International | 4.0% | 9,052,483 | 1.1B USD | −17.0% reduced | Q2 2023 6 quarters |
| V Visa Inc. | 3.5% | 3,505,747 | 963.9M USD | new | Q3 2024 1 quarter |
| Spotify Technology S A | 3.5% | 2,577,629 | 949.9M USD | +442.7% increased | Q2 2024 2 quarters |
| FTV Fortive | 3.4% | 11,797,420 | 931.2M USD | +17.5% increased | Q3 2019 21 quarters |
| PGR Progressive Corporation | 3.2% | 3,485,875 | 884.6M USD | −13.0% reduced | Q1 2022 11 quarters |
| MSFT Microsoft | 3.2% | 2,044,429 | 879.7M USD | −10.8% reduced | Q1 2024 3 quarters |
| Api Group Corp | 3.1% | 25,710,544 | 849.0M USD | −4.9% reduced | Q2 2020 18 quarters |
| WDAY Workday, Inc. | 2.9% | 3,267,712 | 798.7M USD | −17.5% reduced | Q1 2023 7 quarters |
| BAC Bank of America | 2.9% | 19,959,530 | 792.0M USD | new | Q3 2024 1 quarter |
| JPM JPMorgan Chase | 2.8% | 3,696,535 | 779.5M USD | +22.8% increased | Q2 2024 2 quarters |
| AMZN Amazon | 2.8% | 4,054,633 | 755.5M USD | −56.4% reduced | Q2 2015 38 quarters |
| Biomarin Pharmaceutical Inc | 2.5% | 9,753,293 | 685.6M USD | +38.1% increased | Q4 2021 12 quarters |
| Bridgebio Pharma Inc | 2.3% | 25,120,991 | 639.6M USD | unchanged | Q2 2019 22 quarters |
| Roivant Sciences Ltd | 2.3% | 54,099,066 | 624.3M USD | −21.8% reduced | Q4 2021 12 quarters |
| Flutter Entmt PLC | 2.2% | 2,545,376 | 604.0M USD | new | Q3 2024 1 quarter |
| DASH DoorDash | 1.9% | 3,599,305 | 513.7M USD | −35.0% reduced | Q2 2024 2 quarters |
| SHW Sherwin-Williams | 1.8% | 1,301,656 | 496.8M USD | +219.2% increased | Q2 2024 2 quarters |
| TEAM Atlassian | 1.7% | 2,974,936 | 472.4M USD | +102.9% increased | Q4 2023 4 quarters |
| LVS Las Vegas Sands | 1.6% | 8,665,215 | 436.2M USD | −56.2% reduced | Q1 2024 3 quarters |
| ALL Allstate | 1.4% | 2,042,102 | 387.3M USD | +274.6% increased | Q2 2024 2 quarters |
| MET MetLife | 1.3% | 4,487,602 | 370.1M USD | new | Q3 2024 1 quarter |
| CPT Camden Property Trust | 1.3% | 2,959,136 | 365.5M USD | −9.2% reduced | Q1 2024 3 quarters |
| Royalty Pharma PLC | 1.2% | 12,094,021 | 342.1M USD | +1.0% increased | Q2 2020 18 quarters |
| Mcdonalds Corp | 1.2% | 1,120,649 | 341.2M USD | −40.3% reduced | Q2 2024 2 quarters |
| CSX CSX Corporation | 1.2% | 9,351,747 | 322.9M USD | +97.4% increased | Q4 2022 8 quarters |
| HCA HCA Healthcare | 1.0% | 698,030 | 283.7M USD | +6.7% increased | Q4 2023 4 quarters |
| VRT Vertiv | 1.0% | 2,813,448 | 279.9M USD | +307.9% increased | Q1 2024 3 quarters |
| NVDA Nvidia | 1.0% | 2,265,322 | 275.1M USD | +63.6% increased | Q2 2024 2 quarters |
| GEV GE Vernova | 0.9% | 1,013,133 | 258.3M USD | −58.3% reduced | Q2 2024 2 quarters |
| Transunion | 0.9% | 2,400,728 | 251.4M USD | new | Q3 2024 1 quarter |
| TMUS T-Mobile US | 0.9% | 1,150,738 | 237.5M USD | −53.8% reduced | Q4 2023 4 quarters |
| KKR KKR & Co. | 0.9% | 1,810,751 | 236.4M USD | +232.2% increased | Q4 2023 4 quarters |
| Acadia Healthcare Company In | 0.9% | 3,701,347 | 234.7M USD | +14.4% increased | Q4 2020 16 quarters |
| VST Vistra Corp. | 0.8% | 1,837,021 | 217.8M USD | new | Q3 2024 1 quarter |
| GOOGL Alphabet Inc. (Class A) | 0.8% | 1,277,458 | 211.9M USD | new | Q3 2024 1 quarter |
| ADSK Autodesk | 0.8% | 762,026 | 209.9M USD | new | Q3 2024 1 quarter |
| CBRE CBRE Group | 0.7% | 1,571,735 | 195.6M USD | −56.6% reduced | Q2 2023 6 quarters |
| AON Aon plc | 0.7% | 563,027 | 194.8M USD | new | Q3 2024 1 quarter |
| INTU Intuit | 0.7% | 289,919 | 180.0M USD | −13.7% reduced | Q2 2024 2 quarters |
| SNPS Synopsys | 0.6% | 351,523 | 178.0M USD | new | Q3 2024 1 quarter |
| CCL Carnival Corporation | 0.6% | 9,559,560 | 176.7M USD | new | Q3 2024 1 quarter |
| SBUX Starbucks | 0.6% | 1,665,162 | 162.3M USD | new | Q3 2024 1 quarter |
| FCX Freeport-McMoRan | 0.6% | 3,140,964 | 156.8M USD | −39.9% reduced | Q3 2023 5 quarters |
| Adaptive Biotechnologies Cor | 0.6% | 29,993,708 | 153.6M USD | unchanged | Q2 2019 22 quarters |
| SCHW Charles Schwab Corporation | 0.6% | 2,339,956 | 151.7M USD | new | Q3 2024 1 quarter |
| CRM Salesforce | 0.5% | 544,402 | 149.0M USD | +34.4% increased | Q2 2024 2 quarters |
| NFLX Netflix | 0.5% | 204,981 | 145.4M USD | −78.0% reduced | Q2 2024 2 quarters |
| ZS Zscaler | 0.5% | 847,771 | 144.9M USD | new | Q3 2024 1 quarter |
| Integer HLDGS Corp | 0.5% | 1,110,517 | 144.4M USD | −0.1% reduced | Q1 2024 3 quarters |
| Teva Pharmaceutical Inds Ltd | 0.5% | 7,567,533 | 136.4M USD | new | Q3 2024 1 quarter |
| LLY Lilly (Eli) | 0.5% | 152,038 | 134.7M USD | +5.5% increased | Q4 2023 4 quarters |
| Newamsterdam Pharma Company | 0.5% | 8,024,565 | 133.2M USD | unchanged | Q4 2022 8 quarters |
| OSCR Oscar Health | 0.5% | 6,172,132 | 130.9M USD | +4.1% increased | Q1 2024 3 quarters |
| CMCSA Comcast | 0.5% | 3,092,685 | 129.2M USD | new | Q3 2024 1 quarter |
| Equitable HLDGS Inc | 0.5% | 3,050,262 | 128.2M USD | −47.9% reduced | Q1 2024 3 quarters |
| MMM 3M | 0.4% | 840,751 | 114.9M USD | −48.9% reduced | Q2 2024 2 quarters |
| AMP Ameriprise Financial | 0.4% | 243,055 | 114.2M USD | −73.3% reduced | Q1 2021 15 quarters |
| TSLA Tesla, Inc. | 0.4% | 436,272 | 114.1M USD | new | Q3 2024 1 quarter |
| Standard Biotools Inc | 0.4% | 58,651,170 | 113.2M USD | unchanged | Q1 2024 3 quarters |
| Rogers Communications Inc | 0.4% | 2,701,058 | 108.6M USD | new | Q3 2024 1 quarter |
| Regal Rexnord Corporation | 0.4% | 630,121 | 104.5M USD | −43.9% reduced | Q4 2023 4 quarters |
| CSGP CoStar Group | 0.3% | 1,261,195 | 95.1M USD | new | Q3 2024 1 quarter |
| BSX Boston Scientific | 0.3% | 967,210 | 81.1M USD | new | Q3 2024 1 quarter |
| Pharvaris N V | 0.2% | 3,653,310 | 67.7M USD | unchanged | Q1 2021 15 quarters |
| Immunovant Inc | 0.2% | 2,320,902 | 66.2M USD | unchanged | Q1 2024 3 quarters |
| Longboard Pharmaceuticals In | 0.2% | 1,969,041 | 65.6M USD | +18.7% increased | Q1 2024 3 quarters |
| LI Li Auto | 0.2% | 2,075,279 | 53.2M USD | new | Q3 2024 1 quarter |
| REGN Regeneron Pharmaceuticals | 0.2% | 49,870 | 52.4M USD | new | Q3 2024 1 quarter |
| Zai Lab Ltd | 0.2% | 1,949,937 | 47.1M USD | −4.3% reduced | Q1 2021 15 quarters |
| CVNA Carvana | 0.2% | 269,088 | 46.9M USD | −51.4% reduced | Q2 2024 2 quarters |
| Viking Therapeutics Inc | 0.2% | 721,926 | 45.7M USD | −46.7% reduced | Q1 2023 7 quarters |
| Oric Pharmaceuticals Inc | 0.1% | 4,000,000 | 41.0M USD | unchanged | Q1 2024 3 quarters |
| Edgewise Therapeutics Inc | 0.1% | 1,481,146 | 39.5M USD | unchanged | Q1 2021 15 quarters |
| Day One Biopharmaceuticals I | 0.1% | 2,558,563 | 35.6M USD | unchanged | Q2 2021 14 quarters |
| Ginkgo Bioworks Holdings Inc | 0.1% | 3,577,128 | 29.2M USD | new | Q3 2024 1 quarter |
| Inhibrx Biosciences Inc | 0.1% | 1,787,705 | 28.0M USD | unchanged | Q2 2024 2 quarters |
| Trevi Therapeutics Inc | < 0.1% | 4,400,000 | 14.7M USD | unchanged | Q3 2022 9 quarters |
| Pepgen Inc | < 0.1% | 1,482,434 | 12.7M USD | unchanged | Q2 2022 10 quarters |
| Biontech SE | < 0.1% | 46,294 | 5.5M USD | new | Q3 2024 1 quarter |
| Rallybio Corp | < 0.1% | 4,194,777 | 4.9M USD | unchanged | Q3 2021 13 quarters |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Breakdown by sector
- Financials 23.4%
- Technology 18.8%
- Consumer Discretionary 8.0%
- Industrials 7.0%
- Consumer Staples 4.0%
- Communication Services 2.6%
- Real Estate 2.4%
- Materials 2.4%
- Health Care 2.0%
- Utilities 0.8%
- not in our coverage 28.6%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors